Market Cap 20.13M
Revenue (ttm) 0.00
Net Income (ttm) -47.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 2.23
Volume 127,900
Avg Vol 201,458
Day's Range N/A - N/A
Shares Out 12.20M
Stochastic %K 3%
Beta -0.27
Analysts Sell
Price Target $11.00

Latest News on QTTB

Q32 Bio to Participate in Upcoming March Investor Conferences

Feb 26, 2025, 6:59 AM EST - 5 weeks ago

Q32 Bio to Participate in Upcoming March Investor Conferences


Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097

Aug 29, 2024, 3:40 AM EDT - 7 months ago

Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097


Q32 Bio Joins Russell 3000® Index

Jul 1, 2024, 6:59 AM EDT - 9 months ago

Q32 Bio Joins Russell 3000® Index